RayzeBio Prices Upsized $311M Initial Public Offering Of 17,277,600 Common Shares At $18/Share
Portfolio Pulse from Benzinga Newsdesk
RayzeBio has priced its upsized initial public offering (IPO) of 17,277,600 common shares at $18 per share, raising $311 million.
September 15, 2023 | 5:57 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RayzeBio's IPO has been priced at $18 per share, raising $311 million. This could potentially attract investors, leading to a positive impact on the stock price.
The pricing of an IPO can have a significant impact on a company's stock price. In this case, RayzeBio has priced its IPO at $18 per share, which is a significant amount. This could potentially attract investors, leading to an increase in demand for the stock and a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100